For episode 12, we catch up with Vijay Karwal, CFO of Affamed Therapeutics. Find out where there is still a preference for stories that are de risked from the perspective of being closer to revenue and closer to market.

First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder & guest host Co-Founder, Andrew Brackin.

Episodes launch weekly on Tuesdays.

To view the full transcript of this episode, click here.

Interested in being featured as a guest on First In Human? Please reach out to [email protected]. 

🎧 Stay in the Loop!

For the latest news and updates, visit our website: https://vial.com

Follow us on social media for real-time insights:

Twitter: https://twitter.com/VialTrials

LinkedIn: https://www.linkedin.com/company/vialtrials